However the surge in demand-and an international supply chain already crimped by the COVID-19 pandemic and a months-long shortage of computer chips-has forced ResMed to begin rationing out its hardware. RELATED: ResMed looks to fill CPAP gap from Philips' recall, but supplies are short
Meanwhile, the medtech’s sleep care competitor ResMed aims to meet the nightly needs of patients, who the FDA has urged to stop using the recalled devices immediately and contact Philips for a replacement. The recall put a dent in the company’s second-quarter sales, eating up the gains seen from its sales of hospital patient monitoring tech. The difficult situation is being felt on Philips’ side as well. We urge patients with affected active devices to register these on the dedicated recall notification website.” “We have significantly increased our production, service and rework capacity and further intensified our outreach to our customers and their patients. “We are mobilized to deliver a solution to them as fast as possible,” van Houten said. “We fully recognize that the timeframe for remediation of the affected devices places patients in a difficult situation,” CEO Frans van Houten said in a statement. The task is expected to be fully completed within about 12 months. Philips said it has already started replacing older devices with DreamStation 2 CPAP machines and is launching repair programs in other countries as well. RELATED: FDA dishes out Class I label to Philips' recall of faulty CPAP machines and other ventilators The company has now received a green light from the FDA to start replacing the sound abatement foam with a new material and plans to begin the work over the month of September.
0 kommentar(er)
